As median pre-ART CD4 count and ART coverage increases, fewer settings are likely to report differences in CRP sensitivity by HIV status but differences in specificity may persist due to the increased susceptibility to other non-TB diseases associated with HIV infection (e.g., bacterial pneumonia), regardless of CD4 count. The gene discussed is CRP; the disease is HIV infectious disease.